Circurna
PrivateLast Round
Grant
Jan 23, 2024
Total Funding Raised
$4.31M
Momentum Score
25 /100
Company Overview
Circurna is a biotechnology company that is developing next-generation RNA therapeutics using its proprietary ciRNA™ circular RNA platform with programs in oncology, fibrosis, and chronic conditions.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Circurna Comps
Public and private peers based on sector, stage, and business model.
Circurna Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 23, 2024 | ||||
| Grant | Oct 24, 2023 |
Key People
Founding team and executive leadership
Circurna Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CEPI | Grant |
| NIH RADx | Grant |
| DHSC | Grant |
| UKRI Innovate UK | Grant |
| UK Vaccine Network | Grant |
| Innovate UK Contracts for Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Grew 60% QoQ from 5 to 8 employees.
- Jan 22, 2026
Grew 60% QoQ, from 5 to 8 employees.
Circurna Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Circurna's valuation, stock price, and market status.
